For Patients


A commitment to patients. br>A focus on progress.
What we’re working toward
Our research is focused on helping people with:
Conditions that affect how the body uses iron
Anemias caused by chronic illness
Other rare blood diseases with high unmet need
Partnering with the community
At Disc Medicine, we focus on the people we are trying to help—shaping our research and support to meet the real needs of those living with blood disorders. We work with patient organizations, caregivers, and advocacy leaders to ensure the patient voice guides our science at all times. With strong knowledge of how RBCs and iron work in the body, we’re committed to advancing research, supporting education and awareness, and improving access to care through strong community partnerships.

Clinical trials
Joining a clinical trial is a great way to help support the research for potential new treatments. We have ongoing trials in:
Erythropoietic protoporphyria (EPP) and X‑linked protoporphyria (XLP)
Anemia of myelofibrosis
Anemia of non-dialysis-dependent chronic kidney disease
Diamond-Blackfan anemia*
Polycythemia vera
*IIT with NIH.
Patient access
Science is just part of the story. From early development to real-world impact, we’re committed to supporting patient access—so that the medicines we develop can make a difference for as many people as possible. We’re dedicated to making sure patients get the treatment they need.



Patient resources
We’re committed to raising awareness and advancing education around EPP and XLP. That’s why we created PPIX Is Why, an educational resource designed to help patients, caregivers, and providers better understand the root cause of EPP. Follow along and join the conversation on Facebook or Instagram.
Intended for US audiences.